Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Icecure Medical Ltd (NASDAQ: ICCM) was $1.05 for the day, up 1.94% from the previous closing price of $1.03. In other words, the price has increased by $1.94 from its previous closing price. On the day, 0.68 million shares were traded. ICCM stock price reached its highest trading level at $1.05 during the session, while it also had its lowest trading level at $1.02.
Ratios:
Our analysis of ICCM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.02.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICCM now has a Market Capitalization of 72084280 and an Enterprise Value of 58618808. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.85 while its Price-to-Book (P/B) ratio in mrq is 21.73. Its current Enterprise Value per Revenue stands at 21.033 whereas that against EBITDA is -3.771.
Stock Price History:
The Beta on a monthly basis for ICCM is 1.54, which has changed by 0.6773163 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, ICCM has reached a high of $1.63, while it has fallen to a 52-week low of $0.47. The 50-Day Moving Average of the stock is 7.02%, while the 200-Day Moving Average is calculated to be -2.65%.
Shares Statistics:
ICCM traded an average of 1.59M shares per day over the past three months and 3306480 shares per day over the past ten days. A total of 59.82M shares are outstanding, with a floating share count of 40.31M. Insiders hold about 41.31% of the company’s shares, while institutions hold 0.37% stake in the company. Shares short for ICCM as of 1755216000 were 756095 with a Short Ratio of 0.47, compared to 1752537600 on 358410. Therefore, it implies a Short% of Shares Outstanding of 756095 and a Short% of Float of 5.4399999999999995.
Earnings Estimates
Icecure Medical Ltd (ICCM) is presently subject to a detailed evaluation by 2.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.2 and -$0.23 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.17, with 3.0 analysts recommending between -$0.06 and -$0.23.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $828k to a low estimate of $450k. As of the current estimate, Icecure Medical Ltd’s year-ago sales were $662kFor the next quarter, 2 analysts are estimating revenue of $975k. There is a high estimate of $1.2M for the next quarter, whereas the lowest estimate is $750k.
A total of 3 analysts have provided revenue estimates for ICCM’s current fiscal year. The highest revenue estimate was $4.33M, while the lowest revenue estimate was $2.45M, resulting in an average revenue estimate of $3.35M. In the same quarter a year ago, actual revenue was $3.29MBased on 3 analysts’ estimates, the company’s revenue will be $12.28M in the next fiscal year. The high estimate is $26.36M and the low estimate is $5.08M.